BPC-157 Arginate
BPC-157 Arginate Salt (Stable Oral Form)
A stable arginate salt form of BPC-157 designed for oral administration with improved stability and bioavailability compared to standard BPC-157.
Mechanism of Action
BPC-157 Arginate has the same mechanism as standard BPC-157 but with enhanced stability in the GI tract. The arginate salt form resists degradation by stomach acid, improving oral bioavailability.
Health Claims & Evidence
Improved oral bioavailability vs standard BPC-157
Gut healing and anti-inflammatory effects
Systemic tissue repair via oral administration
Short-Term Effects
Improved gut comfort, reduced inflammation. Systemic effects within 1–2 weeks.
Long-Term Effects
Sustained tissue repair and gut health with consistent use.
Side Effects
Generally well-tolerated. Mild nausea in some individuals.
Contraindications
Not recommended during pregnancy or with active cancer.
This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.
Research Papers
BPC-157 oral administration and bioavailability
Sikiric et al. · Current Pharmaceutical Design · 2018
Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.
Related Peptides
Explore the research further
Our AI Research Advisor can help you explore the evidence on BPC-157 Arginate and related peptides, and prepare an educational research summary.
Explore Research